Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib improved multiple immune-related conditions in one patient.

JAK inhibitors may help improve symptoms in adults with APECED.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

TLR3 signaling enhances the immunosuppressive properties of human periodontal ligament stem cells.

Certain proteins, caspases-1 and -11, are important in the early development of skin inflammation in mice.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

Activating PKCα in skin causes cell death and inflammation through different pathways.

JAK inhibitors help hair growth by boosting beta-catenin activity in hair root cells.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Matrix changes and increased MMPs contribute to skin inflammation in hidradenitis suppurativa.

Overexpressing PKCα in mice skin increases inflammation but doesn't affect tumor growth.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

A specific group of immune and skin cells may cause chronic inflammation in atopic dermatitis.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Higher levels of certain proteins in the blood are linked to more severe patchy alopecia areata.

NLRP3 helps control inflammation and repair in wound healing, making it a potential target for treatment.

T cells affect skin cell genes in inflammatory diseases, and therapy can normalize these changes.

SPT6 prevents excessive skin inflammation by blocking a feedback loop.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

IL-9 increases skin cell movement but decreases their ability to invade, and this effect is controlled by cell contractility, not by MMPs.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

A substance called poly(I:C) increases a protein called carbonic anhydrase II in skin cells, which might help with skin defense and healing.

JAK inhibitors might help treat alopecia areata.

IL-1 family cytokines are crucial for skin defense and healing, but their imbalance can cause skin diseases.